Boyle A. Uniform addition of ribavirin to sofosbuvir/velpatasvir for genotype 3 patients with cirrhosis: real world outcomes. THU-285.
Betere uitkomsten COVID-19 dankzij therapeutische antistolling
sep 2021 | Benigne hematologie, Pneumonie, Virale infecties